StockData
Septerna, Inc. logo

Septerna, Inc. (SEPN) stock

SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30165% above fair value
$40.02−1.65 (-3.96%)

Close on Nov 17, 2026Market cap $1.87BP/E –Yield –

Septerna price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Septerna's price to sales ratio was 22.4× on Nov 11, 2026, against 58.8× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202622.4×−34.0
2025Dec 31, 202556.5×−2.7
2024Dec 31, 202459.2×–

More Septerna figures

See a number that looks wrong?